AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca total employee benefit & compensation costs ($M) ($M)
Form 20-F Note 30 — Employee Costs & Numbers
Latest, FY2025
14,548
Period ended Dec 31, 2025
Change on a year earlier
+6.1%
13,709 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total employee benefit & compensation costs ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14,548 | +6.1% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 13,709 | +11.1% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 12,335 | +7.0% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 11,531 | +12.2% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 10,275 | +24.6% | Form 20-F FY2023 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 8,247 | +9.0% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 7,568 | – | Form 20-F FY2022 Annual Report ↗ |
Breakdown
What makes up total employee benefit & compensation costs ($m)
Cite this data
StockData. (2026). AstraZeneca Total employee benefit & compensation costs ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/emp_cost_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.